EMD Serono
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Technology Pl, Rockland, Massachusetts...Phone Number
(877) 447-3243Website
www.mavenclad.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About EMD Serono
EMD Serono specializes in developing MAVENCLAD® (cladribine) Tablets, an oral treatment for adults with relapsing forms of multiple sclerosis (MS), including relapsing-remitting and active secondary progressive disease. The company aims to provide effective solutions for patients who have struggled with other MS medications or have not tolerated them well. EMD Serono emphasizes patient safety and supports clients with resources such as dosing schedules, medical guides, and educational events. Their target clients include adults diagnosed with relapsing MS looking for alternative therapeutic options.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EMD Serono your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
EMD Serono, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at EMD Serono
Check out if EMD Serono is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on EMD Serono recently announced quarterly report
Funding: Get notified immidiatlly once EMD Serono has new funding data
Check if EMD Serono has recently received funding, and reach out quickly before it becomes old news!
Click to see if EMD Serono had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when EMD Serono launches new products
Recommended Actions
Find VP level buyers at EMD Serono
Find 3 more new buyers
Compare Similar Companies to EMD Serono
Compare insights from companies similar to EMD Serono, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
EMD Serono
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
EMD Serono is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
EMD Serono is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about EMD Serono.
EMD Serono Tech Stack
A closer look at the technologies used by EMD Serono
See more technologies
EMD Serono News & Media
Prime Therapeutics and EMD Serono ink value-based agreement on MAVENCLAD® (cladribine) tablets
EAGAN, Minn., June 8, 2020 /PRNewswire/ -- Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving more than 30 million members nationally, signed a value-based agreement with EMD Serono for its oral multiple sclerosis (MS) therapy, MAVENCLAD® (cladribine)...
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EMD Serono
Sign Up For FreeTo access detailed company insights
EMD Serono specializes in developing MAVENCLAD® (cladribine) Tablets, an oral treatment for adults with relapsing forms of multiple sclerosis (MS), including relapsing-remitting and active secondary progressive disease. The company aims to provide effective solutions for patients who have struggled with other MS medications or have not tolerated th... Read More
